About 10X Genomics
10X Genomics (NASDAQ:TXG) is a biotechnology company that focuses on developing and providing advanced genetic analysis systems. These systems are designed to enhance and accelerate genetic research and biological discovery. Their products and services aim to unlock insights into diseases, leading to more effective treatments and therapies. 10X Genomics' portfolio includes innovative technology platforms like Chromium and Visium, which enable scientists to analyze biological systems at a resolution and scale not previously possible. The company's objectives revolve around pushing the boundaries of science to empower researchers and drive advancements in the field of genomics. Through their commitment to innovation, 10X Genomics supports the research community in exploring the complexities of biology at the cellular level, fostering breakthroughs in health and medicine.
Snapshot
Operations
Produtos e/ou serviços de 10X Genomics
- Chromium platform provides comprehensive solutions for analyzing genetic information and cellular structures, enabling insights into biology at a resolution unmatched by other methodologies.
- Visium Spatial Solutions offers a new dimension in tissue analysis, allowing researchers to observe how cells organize and interact in their natural context.
- Single Cell Gene Expression solutions enable the discovery of gene expression dynamics at the single cell level, revolutionizing our understanding of cellular function and complexity.
- Feature Barcoding technology enhances single cell analysis by adding the ability to simultaneously measure gene and protein expression in individual cells.
- CellPlex provides a cost-effective, scalable solution for high-throughput single cell characterization, enabling complex studies across various biological systems and diseases.
- Xenium In Situ Analyzer offers in-depth, spatially resolved, multi-omic analysis of tissue sections, breaking new ground in understanding tissue architecture and function.
equipe executiva do 10X Genomics
- Dr. Serge Saxonov Ph.D.Co-Founder, CEO & Director
- Dr. Benjamin J. Hindson Ph.D.Co-Founder, President, Chief Scientific Officer & Director
- Mr. Adam S. TaichCFO, Treasurer, Principal Financial Officer & Principal Accounting Officer
- Mr. Jim GoodrichChief of Global Operations
- Mr. Michael Schnall-Levin Ph.D.Founding Scientist & CTO
- Ms. Cassie CorneauManager of Investor Relations & Strategic Finance
- Dr. Randy WuGeneral Counsel and Secretary
- Ms. Mennah MoustafaChief Commercial Officer
- Mr. Jens DurruthyAssociate Director of Product Management